Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Asymptomatic Cryptococcal Antigenemia
NCT03002012Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Nov 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sertraline, sponsored by University of Minnesota. Started Nov 2017; status: terminated.
02
Drugs
sertraline
Beyond the preview
Go deeper on NCT03002012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002012.